Since the legalization of medical cannabis prescriptions in Switzerland in 2022, the country’s legal landscape has fundamentally changed — and with it, the scope of work for Dr. med. Nicolai Berardi, based in Zug. While patients previously had to navigate a complex federal approval process, today a standard controlled substance prescription is sufficient.
Evidena Care, a prescribing platform founded by Dr. Berardi, has offered both local consultations and telemedicine advice for medical cannabis patients for over two years. The company now employs four specialized physicians and ranks among the first providers in this sector. The organization experienced strong growth last year.
To provide patients with greater orientation and transparency in this emerging therapy field, Evidena Care has now integrated a comprehensive information and comparison portal into its platform. CEO and chief physician Dr. Berardi emphasizes the importance of this step:
„As the industry has grown, more offerings have emerged — from new pharmacies to a wide variety of strains. At the same time, significant uncertainty remains. Patients have experienced price differences of up to 30% for identical products across different pharmacies. Our new comparison function creates greater transparency.“

However, the new portal is just one of several innovations. Dr. Berardi adds:
„Registered patients with valid prescriptions can now filter pharmacies by product segments such as edibles or vapes. This enables targeted, patient-friendly product searches.“
With these expansions, Evidena Care is taking an important step toward transparency, quality, and patient-centered care in medical cannabis in Switzerland. The platform is increasingly becoming a central point of contact for patients — both in terms of medical consultation and market overview and product selection.
For 2026, Dr. Berardi also forecasts growth of approximately 300%, underscoring the dynamic transformation of the market and the growing demand for professional medical support in this field.




































